Sofie Struyf Selected Research

Interleukin-8A Receptors (Receptors, Interleukin 8A)

1/2012	The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.
10/2011	The expression and role of CXC chemokines in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sofie Struyf Research Topics

Disease

40	Inflammation (Inflammations) 04/2022 - 07/2002
30	Neoplasms (Cancer) 10/2021 - 07/2002
13	Uveitis 04/2022 - 09/2004
13	Infections 12/2019 - 11/2003
11	Neoplasm Metastasis (Metastasis) 01/2012 - 07/2002
9	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 08/2006
6	Epiretinal Membrane (Epiretinal Membranes) 01/2020 - 09/2006
5	Carcinoma (Carcinomatosis) 07/2010 - 07/2002
4	Pathologic Processes 12/2021 - 06/2015
4	Sarcoidosis (Schaumann Disease) 04/2020 - 01/2016
3	Fibrosis (Cirrhosis) 01/2022 - 01/2013
3	Necrosis 01/2020 - 01/2006
3	Autoimmune Diseases (Autoimmune Disease) 08/2019 - 09/2008
3	Rheumatoid Arthritis 12/2018 - 10/2003
3	Virus Diseases (Viral Diseases) 12/2018 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 07/2010
3	Melanoma (Melanoma, Malignant) 11/2014 - 06/2007
2	Breast Neoplasms (Breast Cancer) 10/2021 - 11/2014
2	Hypoxia (Hypoxemia) 01/2021 - 02/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2018 - 07/2004
2	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 04/2018 - 01/2017
2	Atherosclerosis 01/2018 - 02/2011
2	Carcinogenesis 08/2009 - 08/2008
2	Sarcoma (Soft Tissue Sarcoma) 12/2007 - 01/2003
2	Retinal Detachment (Retinal Detachments) 09/2006 - 08/2006
2	Arthritis (Polyarthritis) 09/2006 - 01/2006
2	Crystal Arthropathies 01/2006 - 05/2004
2	Infectious Arthritis (Septic Arthritis) 05/2004 - 11/2003
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2003 - 01/2003
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 04/2022
1	Vitiligo 01/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Familial Mediterranean Fever (Periodic Disease) 01/2021
1	Acute-Phase Reaction 01/2019

Drug/Important Bio-Agent (IBA)

54	ChemokinesIBA 08/2021 - 07/2002
16	CytokinesIBA 04/2020 - 05/2004
13	LigandsIBA 08/2021 - 10/2003
11	Proteins (Proteins, Gene)FDA Link 10/2018 - 07/2002
11	CXC ChemokinesIBA 04/2018 - 05/2004
9	Chemotactic FactorsIBA 04/2018 - 11/2003
7	EnzymesIBA 01/2020 - 09/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2010
6	ImmunosorbentsIBA 01/2020 - 09/2004
5	Interleukin-8 (Interleukin 8)IBA 04/2018 - 01/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 01/2006
4	Peptides (Polypeptides)IBA 01/2022 - 03/2010
4	Protein Isoforms (Isoforms)IBA 08/2021 - 07/2002
4	InterferonsIBA 08/2021 - 11/2003
4	Peptide Hydrolases (Proteases)FDA Link 12/2017 - 06/2004
4	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2010 - 11/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 02/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021 - 02/2011
3	Retinaldehyde (Retinal)IBA 01/2021 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 12/2019 - 01/2016
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2019 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 08/2019 - 05/2011
3	InterleukinsIBA 08/2019 - 07/2010
3	CC ChemokinesIBA 02/2019 - 02/2003
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 02/2005
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 02/2005
3	Interleukin-17 (Interleukin 17)IBA 08/2012 - 12/2007
3	Interferon-gamma (Interferon, gamma)IBA 07/2010 - 11/2003
3	Chemokine ReceptorsIBA 06/2010 - 09/2006
2	Rituximab (Mabthera)FDA Link 04/2022 - 01/2021
2	Monoclonal AntibodiesIBA 04/2022 - 01/2021
2	GlycosaminoglycansIBA 01/2022 - 12/2021
2	Caspase 3 (Caspase-3)IBA 01/2021 - 02/2015
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2019 - 06/2015
2	Interleukin-6 (Interleukin 6)IBA 12/2019 - 01/2016
2	Chemokine CXCL12IBA 01/2016 - 07/2010
2	Interleukin-15 (Interleukin 15)IBA 08/2012 - 05/2011
2	Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA 01/2012 - 10/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2010 - 03/2007
2	Chemokine CXCL6IBA 12/2007 - 04/2007
2	Chemokine CCL4IBA 09/2006 - 10/2002
2	Chemokine CCL3IBA 09/2004 - 10/2002
2	Chemokine CCL18IBA 11/2003 - 07/2002
1	gag Gene Products (gag Protein)IBA 12/2021
1	matrigelIBA 10/2021
1	PyrinIBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Tissue Inhibitor of Metalloproteinase-3IBA 01/2021
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2021
1	Streptozocin (Streptozotocin)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Interleukin-11 (Interleukin 11)IBA 04/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2020
1	Interleukin-12 Subunit p40IBA 04/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2020
1	Cytokine Receptor gp130IBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 12/2019
1	Interleukin-1 (Interleukin 1)IBA 12/2019
1	AntigensIBA 08/2019
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2019

Therapy/Procedure

10	Therapeutics 04/2022 - 06/2007
1	Cautery 10/2021
1	Immunomodulation 01/2021